AHMEDABAD/BENGALURU, India (Reuters) - Indian drugmaker Lupin Ltd has shut one of its manufacturing plants in western Gujarat state after employees at the site tested positive for COVID-19, two ...

A fourth Lupin manufacturing facility in India has been flagged for violations, the company revealed in a Thanksgiving Day regulatory filing. The FDA has slapped (PDF) Lupin with another Form 483 ...

India's pharmaceutical manufacturing industry is no stranger to the novel coronavirus after multiple waves of infections have temporarily shut down operations at a number of drugmakers' sites. Now, a ...

MUMBAI (Reuters) - The U.S. Food and Drug Administration (FDA) has raised concerns over production processes at a plant that makes oral contraceptives operated by Lupin Ltd, India's fourth-largest ...

CORAL SPRINGS, FL — Global drugmaker Lupin Pharmaceuticals plans to build a $250 million manufacturing plant in Coral Springs, bringing more than 200 skilled jobs to the city by 2030, the company ...

MUMBAI, Feb 23 (Reuters) - Indian drugmaker Lupin Ltd said on Monday that the U.S. Food and Drug Administration (FDA) has raised concerns over production processes at the company's Pithampur plant in ...